Post by
Dumbeldorfwhite on Dec 22, 2023 7:26am
Only 11 patients were enrolled in 2023….
I went back to last years year end NR and there were 52 patients enrolled at that time. That is such a disappointing enrollment rate. What in the companies experience makes them think they will get 37 in a year?
Comment by
Kayz88 on Dec 23, 2023 12:37am
https://www.dana-farber.org/clinical-trials/21-224
Comment by
DJDawg on Dec 23, 2023 10:48am
Yes. that one. When you look at the date that the page was made it dates from late Oct this year so someone put up the page new and they are hopefully finalizing things before switching to "enrolling now".
Comment by
DeathXray33 on Dec 24, 2023 10:55am
My unsolicited opinion to certain posters here is ; forget about this company and buy a "Total stock market index fund" ...
Comment by
Benedictus on Dec 23, 2023 11:22pm
Yes, let's hope so. Roger's exact words were "we're laying in guidelines and direction in order to treat those 37 patients in 2024". I have no idea what that means. Whether it's more CSS's or his expectation that BTD approval will dramatically hasten enrollment, hopefully we do see a material increase in enrollment.
Comment by
Dumbeldorfwhite on Dec 23, 2023 3:13pm
6 patients in an entire year!?!?! Yet the fanboys here would never mention it. Serious question do the literally pay these sites to recruit people upfront?